Clinical Trial Update: Dose Response Study in Japanese Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial in Japanese patients with Type 2 Diabetes sponsored by AstraZeneca was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2 | Status: TERMINATED